Let There Be (Laser) Light - How Updated EGS Guidelines Impact Market Adoption of our Technology
The Glaucoma Treatment That Only Takes Seconds
Listen to this podcast with CEO Daria Lemann Blumenthal about her journey as a woman in medtech.
Read this candid interview with CEO Daria Lemann-Blumenthal
Opinion piece on 'Glaucoma care in a matter of seconds'
Listen (in Hebrew) as Yaakov Eichler interviews Dr. Modi Goldenfeld about regular glaucoma exams and BELKIN Vision’s technology.
BELKIN Vision Completes $12.25 Series B Financing Round
BELKIN Vision Announces $12.2M Raised in Series B Funding
Pushing Boundaries with Advanced Technologies
Company Showcase
Emerging Glaucoma Devices See Beyond IOP
BELKIN Vision COVID-19 update